8-K
Current Report
Tempest Therapeutics, Inc. Filed Acc 0001544227-21-000005
Exit or restructuring costs · Executive or director change
- Item 2.05 Costs associated with exit or disposal activities
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading mlnd-20210128x8k.htm…